</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
CB Partner Webinar ZOETIS {{webinarspromoemail3::client_only_logo}} {{webinarspromoemail3::client_only_logo_self_hosted}} {{webinarspromoemail3::client_only_logo_alt}} {{webinarspromoemail3::client_only_logo_width}} {{webinarspromoemail3::client_only_logo_custom_css}} {{webinarspromoemail3::client_color}} {{webinarspromoemail3::client_color_darker}} Anti{nbh}Nerve Growth{br}Factor {amp} Monoclonal{br}Antibody Therapy true 1 Credit Hour {{webinarspromoemail3::on_demand}} November 21, 2022 at 8:00 PM {{webinarspromoemail3::remove_webinar_date_and_time_1}} ET 1{nbs}HR The Latest in Controlling{br}Feline Osteoarthritis Pain SAVE YOUR SEAT https://event.on24.com/wcc/r/3932006/D892F3A4375B25513BE8BB7318765775 {{webinarspromoemail3::header_background_image_none}} https://cdn.brief.vet/Clients/Zoetis/110322-Zoetis_Webinar/110322_Webinar_Partner_Zoetis_CustomHeader_600x450%401x.jpg https://cdn.brief.vet/Clients/Zoetis/110322-Zoetis_Webinar/110322_Webinar_Partner_Zoetis_CustomHeader_600x450%402x.jpg {{webinarspromoemail3::header_background_image_1}} {{webinarspromoemail3::header_background_image_2}} {{webinarspromoemail3::header_background_image_3}} {{webinarspromoemail3::header_background_image_4}} {{webinarspromoemail3::header_background_image_5}} {{webinarspromoemail3::header_background_image_6}} {{webinarspromoemail3::supported_by}} /uploads/110322_webinar_partner_zoetis_artboard_46_2_x-1de261b08205b5b265ff156624d984f8.jpg {{webinarspromoemail3::client_logo_self_hosted}} 62 {{webinarspromoemail3::client_logo_alt}} {{webinarspromoemail3::client_logo_url}} {{webinarspromoemail3::place_logos_below_content}} true /uploads/050222_webinar_partner_zoetis_email_speaker_grubb_2_x-bb3ce9de022cac729c5ce50f1fd9e198.jpg {{webinarspromoemail3::speaker_image_self_hosted_1}} Tamara Grubb DVM, PhD, DACVAA {{webinarspromoemail3::speaker_image_2}} {{webinarspromoemail3::speaker_image_self_hosted_2}} {{webinarspromoemail3::speaker_name_2}} {{webinarspromoemail3::speaker_title_2}} {{webinarspromoemail3::speaker_image_3}} {{webinarspromoemail3::speaker_image_self_hosted_3}} {{webinarspromoemail3::speaker_name_3}} {{webinarspromoemail3::speaker_title_3}} {{webinarspromoemail3::speaker_image_4}} {{webinarspromoemail3::speaker_image_self_hosted_4}} {{webinarspromoemail3::speaker_name_4}} {{webinarspromoemail3::speaker_title_4}} {{webinarspromoemail3::speaker_image_5}} {{webinarspromoemail3::speaker_image_self_hosted_5}} {{webinarspromoemail3::speaker_name_5}} {{webinarspromoemail3::speaker_title_5}} {{webinarspromoemail3::speaker_image_6}} {{webinarspromoemail3::speaker_image_self_hosted_6}} {{webinarspromoemail3::speaker_name_6}} {{webinarspromoemail3::speaker_title_6}} true {{webinarspromoemail3::place_speakers_below_content}} Watch out—there’s a new kid on the block for the control of feline osteoarthritis pain. Did you know nerve growth factor (NGF) has recently been found to not only activate pain but perpetuate the pain cycle, leading to the development of maladaptive pain? Don’t miss out on this webinar to see how monoclonal antibody therapy can target maladaptive pain and lead to successful OA management. {{webinarspromoemail3::inside_the_webinar_2}} {{webinarspromoemail3::inside_the_webinar_3}} How to identify OA pain in cats Appreciate why and how untreated pain is highly detrimental to our patients Recognize the role of NGF in the development of chronic, maladaptive pain Understand how an anti{nbh}NGF monoclonal antibody can control OA pain in cats {{webinarspromoemail3::what_youll_learn_5}} {{webinarspromoemail3::what_youll_learn_6}} Save your seat for this webinar to{br}see how this research is changing{br}the game when it comes to controlling{br}OA pain in our feline patients. SAVE YOUR SEAT This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
Anti{nbh}Nerve Growth Factor {amp} Monoclonal Antibody Therapy
Produced by Clinician's Brief & ZOETIS
RACE approved (1 Credit Hour)(1 Credit Hour)
RACE approved (1 Credit Hour)(1 Credit Hour)
Anti{nbh}Nerve Growth{br}Factor {amp} Monoclonal{br}Antibody Therapy
The Latest in Controlling{br}Feline Osteoarthritis Pain
Nov 21, 2022
08:00 PM ET (1{nbs}HR)
SAVE YOUR SEAT
SAVE YOUR SEAT
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}
 
Speaker
Tamara Grubb
DVM, PhD, DACVAA
Inside the Webinar
Inside the Webinar
Watch out—there’s a new kid on the block for the control of feline osteoarthritis pain. Did you know nerve growth factor (NGF) has recently been found to not only activate pain but perpetuate the pain cycle, leading to the development of maladaptive pain? Don’t miss out on this webinar to see how monoclonal antibody therapy can target maladaptive pain and lead to successful OA management.
What you'll learn
  • How to identify OA pain in cats
  • Appreciate why and how untreated pain is highly detrimental to our patients
  • Recognize the role of NGF in the development of chronic, maladaptive pain
  • Understand how an anti{nbh}NGF monoclonal antibody can control OA pain in cats
Save your seat for this webinar to{br}see how this research is changing{br}the game when it comes to controlling{br}OA pain in our feline patients.
SAVE YOUR SEAT
Save your seat for this webinar to{br}see how this research is changing{br}the game when it comes to controlling{br}OA pain in our feline patients.
SAVE YOUR SEAT
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}
 
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
Anti{nbh}Nerve Growth Factor {amp} Monoclonal Antibody Therapy
Produced by Clinician's Brief & ZOETIS
RACE approved (1 Credit Hour)(1 Credit Hour)
RACE approved (1 Credit Hour)(1 Credit Hour)
Anti{nbh}Nerve Growth{br}Factor {amp} Monoclonal{br}Antibody Therapy
The Latest in Controlling{br}Feline Osteoarthritis Pain
Nov 21, 2022
08:00 PM ET (1{nbs}HR)
SAVE YOUR SEAT
SAVE YOUR SEAT
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}
 
Speaker
Tamara Grubb
DVM, PhD, DACVAA
Inside the Webinar
Inside the Webinar
Watch out—there’s a new kid on the block for the control of feline osteoarthritis pain. Did you know nerve growth factor (NGF) has recently been found to not only activate pain but perpetuate the pain cycle, leading to the development of maladaptive pain? Don’t miss out on this webinar to see how monoclonal antibody therapy can target maladaptive pain and lead to successful OA management.
What you'll learn
  • How to identify OA pain in cats
  • Appreciate why and how untreated pain is highly detrimental to our patients
  • Recognize the role of NGF in the development of chronic, maladaptive pain
  • Understand how an anti{nbh}NGF monoclonal antibody can control OA pain in cats
Save your seat for this webinar to{br}see how this research is changing{br}the game when it comes to controlling{br}OA pain in our feline patients.
SAVE YOUR SEAT
Save your seat for this webinar to{br}see how this research is changing{br}the game when it comes to controlling{br}OA pain in our feline patients.
SAVE YOUR SEAT
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}